The small intestine contains CD4 + CD8aa + double-positive intraepithelial lymphocytes (DP IELs), which originate from intestinal CD4 + T cells through down-regulation of the transcription factor Thpok and have regulatory functions. DP IELs are absent in germ-free mice, which suggests that their differentiation depends on microbial factors. We found that DP IEL numbers in mice varied in different vivaria, correlating with the presence of Lactobacillus reuteri. This species induced DP IELs in germ-free mice and conventionally-raised mice lacking these cells. L. reuteri did not shape the DP-IEL-TCR (TCR, T cell receptor) repertoire but generated indole derivatives of tryptophan that activated the aryl-hydrocarbon receptor in CD4 + T cells, allowing Thpok down-regulation and differentiation into DP IELs. Thus, L. reuteri, together with a tryptophan-rich diet, can reprogram intraepithelial CD4 + T cells into immunoregulatory T cells.
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The small intestine contains CD4 + CD8aa + double-positive intraepithelial lymphocytes (DP IELs), which originate from intestinal CD4 + T cells through down-regulation of the transcription factor Thpok and have regulatory functions. DP IELs are absent in germ-free mice, which suggests that their differentiation depends on microbial factors. We found that DP IEL numbers in mice varied in different vivaria, correlating with the presence of Lactobacillus reuteri. This species induced DP IELs in germ-free mice and conventionally-raised mice lacking these cells. L. reuteri did not shape the DP-IEL-TCR (TCR, T cell receptor) repertoire but generated indole derivatives of tryptophan that activated the aryl-hydrocarbon receptor in CD4 + T cells, allowing Thpok down-regulation and differentiation into DP IELs. Thus, L. reuteri, together with a tryptophan-rich diet, can reprogram intraepithelial CD4 + T cells into immunoregulatory T cells.
T he gut microbiota drives maturation and function of the immune system (1-3). Several bacterial taxa shape the differentiation of naïve T cells: Segmented filamentous bacteria (SFB) bias CD4 + T cells toward a T helper 17 (T H 17) cell fate (4), Clostridia clusters IV and XIVa promote CD4 + regulatory T cell (T reg ) differentiation (5, 6) , and Bacteroides fragilis (7, 8) and Faecalibacterium prausnitzii (9) induce CD4 + T cells that secrete interleukin-10 (IL-10). The small intestinal epithelium contains a distinctive population of CD4 + CD8aa + T cell receptor (TCR) ab T cells [referred to as doublepositive intraepithelial lymphocytes (DP IELs)] (10). These cells have a regulatory function complementary to that of T regs and promote tolerance to dietary antigens (11) . DP IELs originate from lamina propria CD4 + T cells that include but are not limited to T regs (11) . Upon reaching the epithelium, these cells reactivate the CD8 + T cell lineage program through down-regulation of Thpok and up-regulation of Runx3 and T-bet (12) (13) (14) . This process is facilitated in part by transforming growth factor-b (TGFb), retinoic acid, interferon-g (IFN-g), and IL-27 (12, 14) . The lack of DP IELs in germ-free (GF) mice (11, 13) indicates that the intestinal microbiota is required for their differentiation, although the bacterial taxa and metabolites required are not known.
We observed that mice born at one of our vivaria [specialized research facility (SRF)] harbored substantial numbers of DP IELs (DP + ), whereas DP IELs were negligible or absent (DP -) in mice from another vivarium [clinical sciences research building (CSRB)] (Fig. 1A) . Moreover, DP IELs in SRF mice expressed low levels of the transcription factor Thpok (Thpok lo ), whereas CSRB mice lacked CD4 + Thpok lo IELs (13), consistent with the observed lack of DP IELs ( fig. S1 ). Thus, the microbiota in SRF mice may contain taxa capable of inducing DP IELs. Consistent with this, DP IELs appeared in CSRB mice after gavage with fecal or ileal microbiota from SRF but not CSRB animals (Fig. 1B) .
Most SRF (DP + ) mice are embryo-rederived using female recipient mice from Charles River (CR) Laboratories and thus acquire a CR microbiota. In contrast, most CSRB (DP -) mice originate from the Jackson Laboratories (JAX). Thus, taxa present in CR but not JAX mice may induce DP IELs. C57BL/6 mice purchased from CR had a DP + phenotype, whereas C57BL/6 mice purchased from JAX had a DP -phenotype (Fig.  1C) . DP + and DP -phenotypes were vertically transmissible (Fig. 1D) . Moreover, the DP + phenotype was laterally transferable from CR to JAX mice by cohousing animals (Fig. 1E) or by colonizing JAX mice with CR ileal or fecal microbiota (Fig. 1F) . Treatment of CR mice with vancomycin, neomycin, ampicillin, and metronidazole (VNAM) abrogated DP IELs (Fig. 1G) , as did ampicillin and vancomycin alone, which target Gram-positive bacteria. Treatment with neomycin, which targets Gram-negative bacteria, led to a slight increase in DP IELs (Fig. 1H) ; metronidazole did not affect DP IELs. Thus, DP IELs are induced by neomycin-resistant Grampositive bacterial taxa.
To define bacterial taxa that induce DP IELs, we sequenced polymerase chain reaction amplicons from 16S ribosomal RNA (rRNA) genes present in the ileum of CR and JAX mice, as well as neomycin-treated and untreated CR animals. Six operational taxonomic units (OTUs) were selectively present in the CR microbiota and were also present or enriched after neomycin treatment ( fig. S2A ). These OTUs included L. reuteri and five members of the Bacteroidales S24-7 lineage (Fig. 2A, fig. S2A , and table S1). L. reuteri was present in the ileum of CR control mice and CR mice treated with neomycin or metronidazole but absent in CR mice treated with ampicillin plus vancomycin ( fig. S2B) .
Two L. reuteri strains (WU and 100-23) induced DP IELs after colonization of JAX mice (Fig. 2B) , whereas L. johnsonii, L. murinus (Fig.  2C) , and various Bacteroides species (Fig. 2D ) did not. As expected, DP IELs were absent throughout the small intestines of GF animals (11, 13) (Fig. 2E ). Concurrent inoculation of GF mice with L. reuteri (WU strain) and ileal microbiota from JAX mice induced DP IELs, whereas JAX ileal microbiota alone was ineffective (Fig. 2F) . Monocolonization with L. reuteri resulted in a slight increase of DP IELs. As expected, the transfer of CR intestinal microbiota induced DP IELs. Thus, L. reuteri induces DP IELs, but the presence of other microbes enhances this effect, perhaps by expanding the CD4 + T cells in the lamina propria and epithelium.
We next examined how L. reuteri induces DP IELs. If L. reuteri antigens shape the specificity of DP IELs, these cells would express quasi-clonal TCR ab repertoires, as shown for SFB-specific T H 17 cells (15) . Analysis of TCR Vb expression on DP IELs, CD4 + IELs, and mesenteric lymph node (MLN) naïve CD4 + T cells showed that TCR Vb usage of DP IELs resembled that of CD4 + IELs but was different from that of naïve CD4 + T cells (Fig. 3A) . In each mouse analyzed, DP IELs exhibited a preferential Vb usage (more than twofold compared with MLN), although no enrichment for a specific Vb pattern was shared by all mice, suggesting mouse-to-mouse variability in DP IEL TCRs ( Statistical analysis was performed using a Mann-Whitney U test between groups or a Kruskal-Wallis test for multiple comparison analysis. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Bars represent means. and germ-free (GF) C57BL/6 mice. Duo, duodenum; je, jejunum; ile, ileum.
(F) Total number of DP IELs in GF mice colonized with JAX ileal microbiota, JAX ileal microbiota combined with L. reuteri WU, L. reuteri WU alone, or CR ileal microbiota. Symbols represent individual mice. Data are pooled from one to three independent experiments. Statistical analysis was performed using a Mann-Whitney U test between groups or a Kruskal-Wallis test for multiple comparison analysis. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. NS, not significant. Bars represent means; error bars indicate SEM.
from those of naïve CD4 + T cells (Fig. 3C) , consistent with the expansion of T cell clones in response to specific antigens. Moreover, the TCR a repertoires of DP IELs and CD4 + IELs were similar but distinct from those of CD8 + IELs (Fig. 3, D and E) , corroborating that DP IELs differentiate from CD4 + IELs. Although the TCR a repertoires of naïve T cells were similar in all mice analyzed, the TCR a repertoires of DP IELs and CD4 + IELs were quite distinct in each mouse (Fig. 3F) , suggesting that the specificity of CD4 + IELs and DP IELs is shaped by various environmental and/or self-antigens in each mouse, rather than by a single antigen.
Some bacterial taxa shape T cell differentiation via their physical components [e.g., polysaccharide A (7, 18)] or their metabolic products [e.g., short-chain fatty acids (19) (20) (21) ]. L. reuteri releases reuterin (22) and histamine (23) and also has the ability to metabolize tryptophan (L-Trp) to indole derivatives, some of which activate the aryl-hydrocarbon receptor (AhR) in group 3 innate lymphoid cells (ILC3s) (24, 25) . Accordingly, culture supernatants of L. reuteri grown in L-Trp-containing medium activated an AhR reporter cell line, whereas supernatants of L. johnsonii or L. murinus did not (Fig. 4A) . To determine whether L. reuteri induces DP IELs through the release of AhR ligands, we added L. reuteri culture supernatants to naïve ovalbumin-specific CD4 + T cells (OTII) stimulated with ovalbumin peptide-pulsed dendritic cells (DCs) with or without TGFb (12) . L. reuteri culture supernatant induced CD8aa
+ T cell differentiation of OTII T cells, as did the AhR agonist 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (Fig. 4B and fig. S4A ), but only in the presence of TGFb. The AhR antagonist CH223191 inhibited CD8aa + CD4
+ T cell differentiation, confirming that the L. reuteri supernatant acts through AhR. AhR agonists in combination with TGFb were as effective as TGFb plus retinoic acid and IFN-g (12, 14) (Fig. 4B) . We also generated a strain of L. reuteri lacking a functional aromatic aminotransferase and, hence, the ability to convert amino acids into indolic AhR ligands (L. reuteri DArAT) (24, 26) . Culture supernatants from L. reuteri DArAT failed to stimulate the AhR reporter cells (Fig. 4C) . Moreover, L. reuteri DArAT did not induce DP IELs in JAX mice (Fig. 4D) , although this strain colonized mice efficiently ( fig. S4B ).
We next assessed the impact of dietary L-Trp levels in DP IEL development. More DP IELs were observed in CR mice fed a diet high in L-Trp (0.48%) compared with mice fed standard (0.24%) or low (0.11%) L-Trp diets (Fig. 4E) . However, a high L-Trp diet failed to induce DP IELs in GF mice monocolonized with either L. reuteri 100-23 or L. reuteri DArAT (fig. S4C) . Thus, L. reuteri acts together with a complex microbiota and dietary L-Trp to induce DP IELs. Bioactivity-guided fractionation of L. reuteri 100-23 supernatant identified the presence of indole-3-lactic acid (ILA), an indole derivative of L-Trp, which activated the AhR reporter cell line and induced CD8aa + CD4 + T cells (fig. S5 ). This compound was as effective as indole-3-aldehyde, which activates AhR in ILC3s (24) (Fig. 4F and fig. S4D ). Ahr -/-mice lacked DP IELs, whereas these cells were present in Ahr +/-littermates and WT controls, supporting our observation that L. reuteri induces DP IELs through the release of AhR ligands (Fig. 4G) . We next asked whether AhR drives DP IEL differentiation in a T cell-intrinsic or -extrinsic fashion. (Fig. 4I and fig. S4, F and G (Fig. 4J ). Thus, a lack of AhR signaling arrests DP IEL development before Thpok down-regulation occurs.
Our study reveals that L. + IELs into DP IELs. Other indole derivatives may have a similar effect. This Ahr-mediated mechanism is distinct from those by which AhR affects other T cells with regulatory functions (T r 1, T regs ), intraepithelial gd T cells, and DCs (27) (28) (29) (30) (31) (32) . Yet undefined microbial species and dietary and/or self-antigens are necessary to expand the CD4 + IEL population with a diverse TCR repertoire that converts into DP IELs. The complete reliance of DP IELs on a single species (L. reuteri) and its tryptophan metabolites for their final maturation may provide a basis for the use of L. reuteri as a probiotic and tryptophanrich food to treat disorders that may be modifiable by DP IELs, such as inflammatory bowel diseases (11) .
